InvestorsObserver
×
News Home

Should Drug Manufacturers - Specialty & Generic Stock 4Front Ventures Corp (FFNTF) Be in Your Portfolio Friday?

Friday, December 03, 2021 03:00 PM | InvestorsObserver Analysts

Mentioned in this article

Should Drug Manufacturers - Specialty & Generic Stock 4Front Ventures Corp (FFNTF) Be in Your Portfolio Friday?

The 31 rating InvestorsObserver gives to 4Front Ventures Corp (FFNTF) stock puts it near the middle of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 65 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, FFNTF’s 31 overall rating means the stock scores better than 31 percent of all stocks.

Overall Score - 31
FFNTF has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on FFNTF!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With 4Front Ventures Corp Stock Today?

4Front Ventures Corp (FFNTF) stock is trading at $1.04 as of 2:44 PM on Friday, Dec 3, a loss of -$0.03, or -2.79% from the previous closing price of $1.07. The stock has traded between $1.03 and $1.10 so far today. Volume today is 550,962 compared to average volume of 677,659. Click Here to get the full Stock Report for 4Front Ventures Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App